Compare OOMA & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OOMA | MLAB |
|---|---|---|
| Founded | 2003 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 517.6M | 533.0M |
| IPO Year | 2015 | 1995 |
| Metric | OOMA | MLAB |
|---|---|---|
| Price | $19.03 | $108.79 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $18.77 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 231.3K | 103.1K |
| Earning Date | 05-27-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | ★ 188.46 | 99.24 |
| EPS | 0.23 | ★ 1.95 |
| Revenue | ★ $114,490,000.00 | N/A |
| Revenue This Year | $20.35 | $6.07 |
| Revenue Next Year | $4.17 | $5.41 |
| P/E Ratio | $82.28 | ★ $56.00 |
| Revenue Growth | ★ 9.53 | N/A |
| 52 Week Low | $9.79 | $59.63 |
| 52 Week High | $19.59 | $115.35 |
| Indicator | OOMA | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 66.34 | 62.63 |
| Support Level | $10.95 | $94.01 |
| Resistance Level | $19.56 | N/A |
| Average True Range (ATR) | 0.70 | 4.88 |
| MACD | -0.08 | 0.17 |
| Stochastic Oscillator | 72.89 | 82.14 |
Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that delivers voice and collaboration features, including messaging, intelligent virtual attendants, and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.